Abstract:Background: Infection by common viruses has long been discussed in the aetiology of a number of autoimmune diseases, including rheumatoid arthritis (RA). However, studies investigating this hypothesis in RA show conflicting results. These studies often lack well-matched control populations, and many do not include data on autoantibodies, genetic risk factors and other environmental factors, which are known to contribute to disease only in subgroups of patients. In the present study, we have therefore examined the role of Epstein-Barr virus (EBV), cytomegalovirus (CMV) and parvovirus B19 (B19) in RA aetiology, by analysing anti-viral antibodies in relation to anti-citrullinated protein antibodies (ACPA), smoking, HLA-DRB1 shared epitope (SE) alleles, and clinical parameters, in both RA patients and matched controls. Methods: Anti-viral antibodies were measured by ELISA in serum samples from 990 RA patients and 700 controls from the Swedish population-based Epidemiological Investigation of RA (EIRA) cohort. Data on ACPA, smoking, SE, inflammation (C-reactive protein) and disease activity score in 28 joints (DAS28) was obtained from the EIRA database. Fisher's exact test, the chi-squared test, and the Mann-Whitney U test were used to calculate differences in anti-viral antibody frequencies and levels; unconditional logistic regression was used to determine the association of anti-viral antibodies with different RA subsets. Results: Antibodies against all viruses were highly prevalent in EIRA, with no major differences detected between ACPA-positive RA, ACPA-negative RA and controls. However, both anti-B19 and anti-EBV IgG levels were significantly lower in ACPA-positive RA compared to controls, and there were significant interactions between low levels of anti-B19 and anti-EBV antibodies and SE in the development of ACPA-positive RA. Conclusion: We could not detect an association between RA and elevated anti-viral antibody levels, for any of the three common viruses, EBV, CMV or B19. On the contrary, our study demonstrated association between low anti-EBV/anti-B19 antibody levels and ACPA-positive RA, in particular when HLA-DRB1 SE was present. These data could potentially suggest that high anti-viral antibody levels would be protective against ACPA-positive RA. Further investigations are required to address the mechanisms behind these findings.

Prevalence And Significance Of Antibodies To Citrullinated Human Papilloma Virus-47 E2(345-362) In Rheumatoid Arthritis

Prevalence and Significance of Antibodies to Citrullinated Human Papilloma Virus-47 E2345–362 in Rheumatoid Arthritis

[Significance of Anti-Citrullinated Human Papilloma Virus-47 E2(345-362) Peptide Antibodies in Diagnosis of Early-Stage Rheumatoid Arthritis].

Clinical utility of anti-citrullinated peptide antibodies in patients with rheumatoid arthritis

[Prevalence and Significance of Antibodies to Citrullinated Human Fibrinogen Β67-77 Peptide in Rheumatoid Arthritis].

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

Multiple Antibody Reactivities to Citrullinated Antigens in Sera from Patients with Rheumatoid Arthritis: Association with HLA-DRB1 Alleles

Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

The Autoantibody Response to Cyclic Citrullinated Collagen Type II Peptides in Rheumatoid Arthritis.

Prevalence and clinical significance of antibodies to citrullinated fibrinogen (ACF) in Chinese patients with rheumatoid arthritis

[Significance of antibodies to the citrullinated glucose-6-phosphate isomerase peptides in rheumatoid arthritis].

[Significance of Citrullinated Collagen Type II and Its Antibodies in Rheumatoid Arthritis].

Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis.

Platelets Derived Citrullinated Proteins and Microparticles Are Potential Autoantibodies ACPA Targets in RA Patients

Autoantibodies against citrullinated-lipopolysaccharide binding protein as a novel biomarker in seronegative rheumatoid arthritis

Impact of Citrullination Upon Antigenicity of Fibrinogen

Association of human papillomavirus infection with risk for rheumatoid arthritis: a population-based cohort study

Citrullinated Peptide And Its Relevance To Rheumatoid Arthritis: An Update

Antibodies Against Citrullinated Peptides Are Associated with Clinical and Radiological Outcomes in Patients with Early Rheumatoid Arthritis: a Prospective Longitudinal Inception Cohort Study

The current status of anti-citrullinated protein antibodies and citrullinated protein-reactive B cells in the pathogenesis of rheumatoid arthritis